戻る Agenda
Early Phase Adaptive Designs
Session Chair(s)
Jiaying Lyu
Fudan University / Laiya Consulting Inc.,, China
In recent years, early phase drug development strategies, especially the application of adaptive design, have received more and more attention and discussion from all sides, especially for anti-tumor drugs. In this session, we invited many statisticians and scientists from academia and rindustry to discuss the application of adaptive designs in early phase, such as in FIH dose finding and seamless trials, etc.